Because the expression of PCA3 lncRNA is prostate-restricted and highly amplified specifically in PCa, it is rational to exploit the specificity of its promoter in PCa diagnostic or therapeutic approaches. The gene discussed is PCA3; the disease is posterior cortical atrophy.